MSLN and neoplasm: The ovarian cancer antigen CA125 was identified as a MSLN ligand that mediates heterotypic cellular adhesion, therefore allowing CA125 expressing tumor cells to bind to MSLN expressing mesothelial cells that line organs in the peritoneal cavity such as the peritoneum or omentum [3,8,9,46].